Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hypofractionated Radiotherapy and Concurrent Cisplatin for Locally Advanced Head and Neck Cancer
NCT03194061Unknown
- Sponsor
- Hospital de Amor
- Start
- Jan 2015
- Primary completion
- Aug 2019
- Modality
- Small Molecules
01
Overview
Open-label, single-arm trial of cisplatin in head and neck squamous cell carcinoma (HNSCC), sponsored by Hospital de Amor. Primary endpoints: Rate of patient who could complete the treatment at 5 years and Rate of participants with treatment-related adverse events at 5 years. Status: unknown.
02
Drugs
cisplatin
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT03194061.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03194061.